Cargando…
Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia
BACKGROUND: Safety data regarding exposure to artemisinin-based combination therapy in pregnancy are limited. This prospective cohort study conducted in Zambia evaluated the safety of artemether-lumefantrine (AL) in pregnant women with malaria. METHODS: Pregnant women attending antenatal clinics wer...
Autores principales: | Manyando, Christine, Mkandawire, Rhoda, Puma, Lwipa, Sinkala, Moses, Mpabalwani, Evans, Njunju, Eric, Gomes, Melba, Ribeiro, Isabela, Walter, Verena, Virtanen, Mailis, Schlienger, Raymond, Cousin, Marc, Chipimo, Miriam, Sullivan, Frank M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944339/ https://www.ncbi.nlm.nih.gov/pubmed/20809964 http://dx.doi.org/10.1186/1475-2875-9-249 |
Ejemplares similares
-
Exposure to artemether-lumefantrine (Coartem®) in first trimester pregnancy in an observational study in Zambia
por: Manyando, Christine, et al.
Publicado: (2015) -
From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
por: Sipilanyambe, Naawa, et al.
Publicado: (2008) -
A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia
por: Chanda, Pascalina, et al.
Publicado: (2007) -
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
por: Zurovac, Dejan, et al.
Publicado: (2007) -
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
por: Belew, Sileshi, et al.
Publicado: (2020)